Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- Resource Type
- Article
- Authors
- Tutt, Andrew; Robson, Mark; Garber, Judy E; Domchek, Susan M; Audeh, M William; Weitzel, Jeffrey N; Friedlander, Michael; Arun, Banu; Loman, Niklas; Schmutzler, Rita K; Wardley, Andrew; Mitchell, Gillian; Earl, Helena; Wickens, Mark; Carmichael, James
- Source
- In The Lancet 2010 376(9737):235-244
- Subject
- Primary Research
Articles
- Language
- ISSN
- 0140-6736